iBio Depreciation & Amortization | IBIO

Annual Depreciation & Amortization iBio

2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
558 K	484 K	638 K	674 K	2.28 M	472 K	282 K	179 K	1.37 M	1.33 M	577 K	5 K	3 K	2 K	330 K	377 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.28 M	2 K	597 K

Quarterly Depreciation & Amortization iBio

2026-Q4	2026-Q3	2026-Q2	2026-Q1	2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	411 K	264 K	123 K	5 K	123 K	-	5 K	5 K	120 K	-	5 K	5 K	165 K	-	5 K	49 K	271 K	388 K	122 K	123 K	306 K	823 K	119 K	114 K	97 K	114 K	97 K	71 K	66 K	137 K	66 K	179 K	179 K	179 K	360 K	341 K	338 K	340 K	338 K	326 K	324 K	326 K	324 K	1 K	1 K	2 K	1 K	90 K	1 K	2 K	1 K	88 K	1 K	1 K	1 K	83 K	82.4 K	166 K	82 K	80 K	80 K	161 K	80 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
823 K	1 K	146 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AbbVie ABBV	762 M	$ 263.04	0.49 %	$ 465 B	USA
AbCellera Biologics ABCL	18.4 M	$ 11.41	2.15 %	$ 3.41 B	Canada
Aclaris Therapeutics ACRS	454 K	$ 5.53	6.02 %	$ 678 M	USA
ADC Therapeutics SA ADCT	705 K	$ 1.09	3.74 %	$ 139 M	Schweiz
Evelo Biosciences EVLO	2.06 M	-	-14.46 %	$ 27.9 M	USA
Allakos ALLK	7.72 M	-	-	$ 28.6 M	USA
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Clovis Oncology CLVS	8.5 M	-	-7.23 %	$ 13 M	USA
Chimerix CMRX	94 K	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	1.48 M	-	-	$ 401 M	USA
ADMA Biologics ADMA	8 M	$ 8.61	0.16 %	$ 2.05 B	USA
Eiger BioPharmaceuticals EIGR	275 K	-	-9.21 %	$ 2.55 M	USA
89bio ETNB	38 K	-	-	$ 1.55 B	USA
Freeline Therapeutics Holdings plc FRLN	1.74 M	-	-	$ 384 M	Britain
Fusion Pharmaceuticals FUSN	1.34 M	-	-	$ 1.41 B	Canada
Guardion Health Sciences GHSI	19.4 K	-	-0.31 %	$ 3.64 M	USA
Genocea Biosciences GNCA	1.56 M	-	-15.0 %	$ 3.04 M	USA
Gritstone Oncology GRTS	7.59 M	-	0.42 %	$ 213 M	USA
G1 Therapeutics GTHX	513 K	-	-	$ 370 M	USA
Harpoon Therapeutics HARP	2.36 M	-	-	$ 763 M	USA
Humanigen HGEN	19 K	-	-81.12 %	$ 4.28 M	USA
HOOKIPA Pharma HOOK	2.75 M	-	-6.92 %	$ 79.4 M	USA
Intercept Pharmaceuticals ICPT	592 K	-	-	$ 643 M	USA
IGM Biosciences IGMS	9.11 M	-	-	$ 76.9 M	USA
Intra-Cellular Therapies ITCI	508 K	-	-	$ 13.6 B	USA
Kinnate Biopharma KNTE	799 K	-	-	$ 123 M	USA
Chinook Therapeutics KDNY	3.4 M	-	-	$ 2.6 B	USA
Kaleido Biosciences KLDO	2.4 M	-	-3.69 %	$ 12.4 M	USA
Kronos Bio KRON	1.72 M	-	1.49 %	$ 50.8 M	USA
Karuna Therapeutics KRTX	1.7 M	-	-	$ 12.2 B	USA
Landos Biopharma LABP	577 K	-	0.58 %	$ 144 M	USA
La Jolla Pharmaceutical Company LJPC	111 K	-	-	$ 154 M	USA
LogicBio Therapeutics LOGC	626 K	-	-	$ 229 M	USA
Lumos Pharma LUMO	44 K	-	-	$ 35.3 M	USA
Merrimack Pharmaceuticals MACK	2.23 M	-	-	$ 216 M	USA
Stealth BioTherapeutics Corp MITO	77 K	-	-	$ 23.9 M	USA
Mirati Therapeutics MRTX	2.93 M	-	-	$ 3.3 B	USA
NexImmune NEXI	1.02 M	-	70.13 %	$ 4.12 M	USA
9 Meters Biopharma NMTR	8.52 K	-	-42.97 %	$ 1.05 M	USA
InVivo Therapeutics Holdings Corp. NVIV	60 K	-	-37.48 %	$ 476 K	USA
Oncorus ONCR	3.63 M	-	-8.54 %	$ 3.19 M	USA
OncoSec Medical Incorporated ONCS	257 K	-	31.87 %	$ 1.61 M	USA
Oncternal Therapeutics ONCT	46 K	-	-24.12 %	$ 1.56 M	USA
Opiant Pharmaceuticals OPNT	94.5 K	-	-	$ 109 M	USA
Orchard Therapeutics plc ORTX	2.74 M	-	1.02 %	$ 90.8 M	Britain